**Abstract**

**Objective:** Treatment-resistant schizophrenia is costly. This study evaluated treatment-cost changes following prescription of clozapine in Japanese patients with treatment-resistant schizophrenia.

**Methods:** Thirty-six patients were recruited; five were subsequently excluded because clozapine was discontinued due to side effects. Medical costs (Japanese yen: JPY) of hospital stay and outpatient treatment were investigated separately, and the total medical cost calculated as their sum. Treatment was assessed at 6-month intervals, based on the month in which clozapine therapy began. The 6-month period after starting clozapine therapy was defined as "0," the prior 6-month period as "-0.5 years," and the subsequent 6-months as "0.5 years." Per-capita 6-month mean costs were calculated.

**Results:** Mean costs of hospital stay were JPY 253,306 at -2.5 years, JPY 312,093 at -2 years, JPY 418,900 at -1.5 years, JPY 442,247 at -1 year, JPY 450,538 at -0.5 years, JPY 507,850 at 0 years, JPY 273,679 at 0.5 years, JPY 374,665 at 1 year, and JPY 267,414 at 1.5 years. Mean costs for outpatient treatment were JPY 9,807 at -2.5 years, JPY 10,398 at -2 years, JPY 17,807 at -1.5 years, JPY 23,190 at -1 year, JPY 20,815 at -0.5 years, JPY 42,666 at 0 years, JPY 58,496 at 0.5 years, JPY 60,617 at 1 year, and JPY 62,001 at 1.5 years. Mean total costs were JPY 36,438 at -2.5 years, JPY 41,028 at -2 years, JPY 96,831 at -1.5 years, JPY 144,495 at -1 year, JPY 281,177 at -0.5 years, JPY 477,432 at 0 years, JPY 120,332 at 0.5 years, JPY 74,848 at 1 year, and JPY 72,999 at 1.5 years.

**Conclusion:** Costs of hospital stay and total costs gradually increased before starting clozapine therapy and peaked when clozapine therapy began. Subsequently, outpatient costs slightly increased, but total costs decreased notably. Clozapine therapy is effective in reducing medical costs.
